Evidence Based Practice for Management of Emerging Sexually Transmitted Infection, Mycoplasma Genitalium
Alternative Title
Abstract
This is an evidence-based practice (EPB) recommendation for management of Mycoplasma genitalium presented as a capstone project. It is a critical review analysis on the current data that is available on Mycoplasma genitalium to clinicians in the United States. The EBP data used for review and analysis was focused primarily on World Health Organization (WHO), Center for Disease Control and prevention (CDC) and clinical resource of UpToDate (CDC, 2021; Martin, 2021; WHO, 2021). The data in 2021 European sexually transmitted infection (STI) guidelines, British STI guidelines, Australian STI guidelines, and Canadian STI guidelines on Mycoplasma genitalium were also taken into consideration when developing the EBP recommendation presented in this paper (ASHM, 2018; Canada Mycoplasma genitalium, 2021; Jensen et al., 2021; Soni et al., 2019). The EBP recommendation put forth in this paper will allow a healthcare provider to safely and effectively recognize and manage Mycoplasma genitalium. It is crucial that a clinician be aware on how and when to diagnose and treat Mycoplasma genitalium due to its potential of becoming one of the first untreatable bacterial sexually transmitted infections in the United States (Moi et al., 2015; Unemo & Jensen, 2017).
Description
Capstone Project
Citation
Publisher
Hawaii Pacific University